Research study Program year 2022 Source: CMS Open Payments

An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension

Research payments

$3,662,594

1,529 payments

Through program year 2022, $3,662,594 in research payments was reported against An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension, across 1,529 payments, paid by Allergan Inc..

Paid by: Allergan Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$322,965	78
2020	Research	$2,364,451	1,241
2019	Research	$975,178	210

Breakdown

Who paid Research payments · program years 2019–2022

Allergan Inc. $3,662,594 1,529 payments

Who received the money Research payments · program years 2019–2022

Scott & Christie And Associates Organisation paid for research $512,626 22 payments
Doc Trials LLC Organisation paid for research $370,092 105 payments
Lance K Bergstrom MD Bergstrom Eye Research L Organisation paid for research $206,211 21 payments
Piedmont Eye Center INC-1000037590 Organisation paid for research $138,633 21 payments
Rochester Ophthalmological Organisation paid for research $138,402 29 payments
James Branch Ophthalmology · Mocksville, NC $123,160 20 payments
Advancing Vision Research LLC Gary W Jerkins M Organisation paid for research $118,352 17 payments
Vistar Eye Center INC Organisation paid for research $111,237 20 payments
Trinity Research Group LLC Organisation paid for research $94,943 20 payments
Dct - Shah Research LLC Dba Discovery Clinical T Organisation paid for research $91,696 35 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.